{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.5","value":"-0.3"}]}],"title":"Mobility Index Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0","value":"0.0"}]}],"title":"Self Care Index Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.5","value":"0.3"}]}],"title":"Activity Index Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0","value":"0.0"}]}],"title":"Pain Index Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.0","value":"0.3"}]}],"title":"Anxiety Index Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1193","value":"-0.0035"}]}],"title":"Utility Index US Index Score"}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"EQ-5D-5L is a standardized measure of health status that consists of descriptive system and Visual Analogue scale VAS). The descriptive system comprises dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels (no problems, slight problems, moderate problems, severe problems, extreme problems). Responses are coded so that a '1' indicates no problem, and '5' indicates the most serious problem. The responses for the dimensions are combined in a 5-digit number corresponding to response categories for successive dimensions using a scoring algorithm. The VAS system has endpoints labeled \"the best health you can imagine\" and \"the worst health you can imagine.\" The scale is numbered from 0 to 100 with 0 corresponding to the worst imaginable health state and 100 corresponding to the best imaginable health state. A high score represents a better level of quality of life","dispersionType":"Standard Deviation","groups":[{"description":"JCARH125 IV at dose level 600 x 10\\^6 consisting of CD3+CAR+T cells expansion","id":"OG000","title":"Phase 2 600 x 10^6 Cells"}],"paramType":"MEAN","populationDescription":"All participants who received at least one infusion of JCARH125 with baseline and post-baseline assessment at the respective visit in phase 2 only as prespecified in the protocol","reportingStatus":"POSTED","timeFrame":"Baseline and visit 24 month","title":"Change From Baseline (EQ-5D-5L) Index Score in Phase 2","type":"SECONDARY","unitOfMeasure":"Score on a scale"}